(2017). Long-term drug survival and causes of discontinuation of subcutaneous abatacept in rheumatoid arthritis: 32-month results from a prospective cohort study.
Chicago Style (17th ed.) CitationLong-term Drug Survival and Causes of Discontinuation of Subcutaneous Abatacept in Rheumatoid Arthritis: 32-month Results from a Prospective Cohort Study. 2017.
MLA (8th ed.) CitationLong-term Drug Survival and Causes of Discontinuation of Subcutaneous Abatacept in Rheumatoid Arthritis: 32-month Results from a Prospective Cohort Study. 2017.
Warning: These citations may not always be 100% accurate.